
PGEN
Healthcare · Biotechnology · $1.63B market cap
$4.54-0.12 (-2.6%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +3.5% over 90 days · 30-day revisions 2 up, 1 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 4, 2026 | After the close | 0.09 | 0.08 | -11.1% |
| Aug 4, 2026 | After the close | -0.02 | 0.05 | +350.0% |
| May 13, 2026 | After the close | -0.04 | -0.02 | +50.0% |
| Mar 9, 2026 | Time not confirmed | -0.08 | -0.07 | +20.3% |
| Nov 13, 2025 | After the close | -0.09 | -1.06 | -1077.8% |
| Aug 12, 2025 | After the close | -0.08 | -0.08 | 0.0% |
| May 14, 2025 | After the close | -0.08 | -0.18 | -125.0% |
| Mar 19, 2025 | Time not confirmed | -0.06 | -0.04 | +33.3% |
| Nov 14, 2024 | After the close | -0.09 | -0.09 | 0.0% |
| Aug 14, 2024 | After the close | -0.09 | -0.10 | -11.1% |
| May 14, 2024 | After the close | -0.08 | -0.10 | -25.0% |
| Mar 19, 2024 | After the close | -0.08 | -0.13 | -62.5% |
| Nov 9, 2023 | After the close | -0.08 |
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators,…
| -0.08 |
| 0.0% |
| Aug 9, 2023 | Before the open | -0.10 | -0.08 | +20.0% |
| May 10, 2023 | Before the open | -0.09 | -0.10 | -11.1% |
| Mar 6, 2023 | After the close | -0.12 | -0.11 | +8.3% |
| Nov 9, 2022 | After the close | -0.09 | -0.04 | +55.6% |
| Aug 8, 2022 | After the close | -0.14 | -0.08 | +42.9% |
| May 9, 2022 | After the close | -0.13 | -0.10 | +23.1% |
| Mar 1, 2022 | Before the open | -0.12 | -0.13 | -8.3% |
| Nov 8, 2021 | Before the open | -0.13 | -0.15 | -15.4% |
| Aug 9, 2021 | After the close | -0.12 | -0.10 | +16.7% |
| May 10, 2021 | After the close | -0.15 | -0.11 | +26.7% |
| Mar 1, 2021 | After the close | -0.17 | -0.23 | -35.3% |
| Nov 9, 2020 | Before the open | -0.14 | -0.18 | -28.6% |
| Aug 10, 2020 | After the close | -0.13 | -0.26 | -100.0% |
| May 6, 2020 | After the close | -0.24 | -0.35 | -45.8% |
| Mar 2, 2020 | After the close | -0.29 | -0.28 | +3.4% |
| Nov 12, 2019 | Before the open | -0.25 | -0.35 | -40.0% |
| Aug 8, 2019 | After the close | -0.29 | -0.25 | +13.8% |
| May 9, 2019 | After the close | -0.25 | -0.40 | -60.0% |
| Feb 28, 2019 | After the close | -0.34 | -2.59 | -661.8% |
| Nov 8, 2018 | After the close | -0.23 | -0.44 | -91.3% |
| Aug 13, 2018 | Before the open | -0.23 | -0.51 | -121.7% |
| May 10, 2018 | After the close | -0.24 | -0.32 | -33.3% |
| Mar 1, 2018 | After the close | -0.32 | -0.09 | +71.9% |